Avionco LLC   Report issue

For profit Phase 1
Founded: Moscow Russian Federation (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2014
NCT03074032
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

onc1-0013b (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1